A trove of clinical trial data on how genetics influence various responses to GLP-1 receptor agonists, including weight loss, likely exists, though that data has been difficult to come by
This is why, for so many patients with PsA and RA, biologics only work partially
The same answer applies on Wegovy, Zepbound, and Mounjaro, since the mechanism is appetite suppression in every case
Inagaki, Effects of glucagon-like peptide-1 receptor agonists on cardiovascular and renal outcomes: a meta-analysis and meta-regression analysis
Using a platform like TrimRx allows you to work with providers who tailor the program to your body
Attributing someones PCOS solely to their weight creates unfair blame and shame, she says